These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7258020)

  • 41. [Study on hog cholera-sine erysipelas combined liver vaccine. I. Experimental preparation of combined live vaccine (author's transl)].
    Eto M; Susumi S; Mishima M; Kobori N; Watanabe S
    Igaku Kenkyu; 1980 Aug; 50(6):490-4. PubMed ID: 7304106
    [No Abstract]   [Full Text] [Related]  

  • 42. Safety of a live attenuated Erysipelothrix rhusiopathiae vaccine for swine.
    Neumann EJ; Grinberg A; Bonistalli KN; Mack HJ; Lehrbach PR; Gibson N
    Vet Microbiol; 2009 Mar; 135(3-4):297-303. PubMed ID: 18977618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of antibiotics used as feed additives on the immune effect of erysipelas live vaccine in swine.
    Yamamoto K; Takagi M; Endoh YS; Kijima M; Takahashi T
    J Vet Med B Infect Dis Vet Public Health; 2000 Aug; 47(6):453-60. PubMed ID: 11014067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [100 years of erysipelas prophylaxis: significance and reduction of animal experiments].
    Cussler K; Balks E
    ALTEX; 2001; 18(1):29-33. PubMed ID: 11248847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study on hog cholera-swine erysipelas combined live vaccine. -III. Field trial of vaccination (author's transl)].
    Eto M; Kobori N; Susumi S; Mishima M; Watanabe S
    Igaku Kenkyu; 1981 Mar; 51(1):79-84. PubMed ID: 7324808
    [No Abstract]   [Full Text] [Related]  

  • 46. Humane endpoints in the efficacy testing of swine erysipelas vaccines.
    Johannes S; Hartinger J; Hendriksen CF; Morton DB; Cussler K
    ALTEX; 2003; 20(1):11-5. PubMed ID: 12579350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunogenesis in swine erysipelas].
    Zhakov MS; Vel' LP
    Veterinariia; 1976 Jul; (7):48-51. PubMed ID: 948853
    [No Abstract]   [Full Text] [Related]  

  • 48. Cellular immune responses in cetaceans immunized with a porcine erysipelas vaccine.
    Sitt T; Bowen L; Blanchard MT; Gershwin LJ; Byrne BA; Dold C; McBain J; Stott JL
    Vet Immunol Immunopathol; 2010 Oct; 137(3-4):181-9. PubMed ID: 20579745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fluctuations in susceptibility of pigs to erysipelas depending on age].
    Arsov R; Vodas K; Rashkov D; Georgieva D; Bekiarova N
    Vet Med Nauki; 1978; 15(2):65-71. PubMed ID: 706144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Protein content in fodder and its effect on the immunity of pigs vaccinated against hog cholera, swine erysipelas and colibacteriosis].
    Wasińska B
    Med Weter; 1976 Dec; 32(12):722-7. PubMed ID: 797598
    [No Abstract]   [Full Text] [Related]  

  • 51. [Protective antigens of the swine erysipelas bacterium (Erysipelothrix rhusiopathiae. 2. Further characterization of the protective antigen].
    Rothe F
    Arch Exp Veterinarmed; 1982; 36(2):255-67. PubMed ID: 6808966
    [No Abstract]   [Full Text] [Related]  

  • 52. [Discussion comment on the publications of K.H. Böhm (1974): "Diagnostic value of serologically demonstrable antibodies in chronic swine erysipelas" and "Methodology in the serology of erysipelas"].
    Wellmann GG
    Dtsch Tierarztl Wochenschr; 1975 Oct; 82(10):408-13. PubMed ID: 1104318
    [No Abstract]   [Full Text] [Related]  

  • 53. [Aerosol immunization of pigs against erysipelas].
    Wasiński K
    Med Weter; 1976 Dec; 32(12):719-21. PubMed ID: 1017561
    [No Abstract]   [Full Text] [Related]  

  • 54. [Different frequency of erysipelas endocarditis after experimental infection of different strains of rats].
    Wellmann GG; Reblin LE
    Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(1):10-3. PubMed ID: 7387612
    [No Abstract]   [Full Text] [Related]  

  • 55. Cross protection of mice and swine given live-organism vaccine against challenge exposure with strains of Erysipelothrix rhusiopathiae representing ten serovars.
    Sawada T; Takahashi T
    Am J Vet Res; 1987 Jan; 48(1):81-4. PubMed ID: 3826847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of swine erysipelas vaccine given simultaneously with medicated rations.
    Hopper RJ; Miller ML
    Vet Med Small Anim Clin; 1981 Sep; 76(9):1345-7. PubMed ID: 6916559
    [No Abstract]   [Full Text] [Related]  

  • 57. Towards in vitro potency testing of inactivated erysipelas vaccines.
    Balks E; Wolf C; Loessner H; Werner E
    Dev Biol (Basel); 2012; 134():37-44. PubMed ID: 22888593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Erysipelothrix rhusiopathiae vaccines in pigs by intradermal challenge and immune responses.
    Eamens GJ; Chin JC; Turner B; Barchia I
    Vet Microbiol; 2006 Aug; 116(1-3):138-48. PubMed ID: 16678363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a monoclonal antibody for in vitro potency testing of erysipelas bacterins.
    Henderson LM; Jenkins PS; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():334. PubMed ID: 8785974
    [No Abstract]   [Full Text] [Related]  

  • 60. Development of an enzyme-linked immunosorbent assay for potency testing of erysipelas bacterins.
    Henderson LM; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():333. PubMed ID: 8785973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.